Utilizing Social Determinants of Health Model to Understand Barriers to Medication Adherence in Patients with Ischemic Stroke: A Systematic Review
Issued Date
2023-01-01
Resource Type
eISSN
1177889X
Scopus ID
2-s2.0-85170029147
Journal Title
Patient Preference and Adherence
Volume
17
Start Page
2161
End Page
2174
Rights Holder(s)
SCOPUS
Bibliographic Citation
Patient Preference and Adherence Vol.17 (2023) , 2161-2174
Suggested Citation
Ruksakulpiwat S., Benjasirisan C., Ding K., Phianhasin L., Thorngthip S., Ajibade A.D., Thampakkul J., Zhang A.Y., Voss J.G. Utilizing Social Determinants of Health Model to Understand Barriers to Medication Adherence in Patients with Ischemic Stroke: A Systematic Review. Patient Preference and Adherence Vol.17 (2023) , 2161-2174. 2174. doi:10.2147/PPA.S420059 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/90031
Title
Utilizing Social Determinants of Health Model to Understand Barriers to Medication Adherence in Patients with Ischemic Stroke: A Systematic Review
Other Contributor(s)
Abstract
Introduction: Ischemic strokes and their recurrence create an immense disease burden globally. Therefore, preventing recurrent strokes by promoting medication adherence is crucial to reduce morbidity and mortality. In addition, understanding the barriers to medication adherence related to the social determinants of health (SDoH) could promote equity among persons with ischemic stroke. Objective: To explore the barriers to medication adherence among patients with ischemic stroke through the SDoH. Methods: This systematic review included studies published between January 2018 and December 2022 identified through PubMed, MEDLINE, Web of Science, and CINAHL Plus Full Text. The descriptions of the studies were systematically summarized and discussed based on the SDoH from the US Healthy People 2030 initiative. Results: Eight studies met the inclusion criteria and were included in this review. The most common barrier to adherence was inappropriate medication beliefs, medication side effects, and patient-physician relationship, which relate to the dimensions of healthcare access and quality. Health literacy and health perception, dependent on education access and quality, frequently influenced adherence. Other social determinants, such as financial strain and social and community context, were found to alter adherence behaviors. No study addressed the neighborhood and built environment domain. We found that cognitive impairment is another factor that impacts adherence outcomes among stroke patients. Conclusion: Multifaceted approaches are needed to address the SDoH to improve medication adherence among patients with ischemic stroke. This review emphasized strategies, including patient education, provider-patient communication, social support, health literacy, technology, and policy advocacy to enhance adherence.